AIDS — Medizinische, epidemiologische und psychosoziale Faktoren

  • Hans Jäger
Conference paper

Zusammenfassung

Seit Beginn der 80er Jahre sind der WHO 157191 Fälle (Stand Juni 1989) des AIDS-Vollbildes, auch als CDC-AIDS bezeichnet, bekannt geworden. Schätzungen gehen davon aus, daß weltweit mit ca. 500 000 Erkrankten gerechnet werden muß.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anonymous (1989) Zidovudine in symptomless HIV infection. Lancet 1: 415–416Google Scholar
  2. Broder S (1989) Controlled trial methodology and progress in treatment of the acquired immunodeficiency syndrome (AIDS). Ann Int Med 110: 417–418PubMedGoogle Scholar
  3. Centers for Disease Control (CDC) (1985) Revision of the case definition of AIDS for national reporting United States. Morb Mort Weekly Rep 34: 373–375Google Scholar
  4. Creagh-Kirk T, Doi P, Andrews E et al. (1988) Survival experience among patients with AIDS receiving Zidovudine. JAMA 260: 3009–3015PubMedCrossRefGoogle Scholar
  5. Cotinho RA (1989) Epidemiology and control of AIDS among drug users. V. Int. Conf. of AIDS. Montreal 1989 (Plenarvortrag)Google Scholar
  6. Fabricius EM (1988) Ophthalmologie. In: Jäger H (Hrsg) AIDS und HIV-Infektionen. Ecomed, LandsbergGoogle Scholar
  7. Fischl MA, Dickinson SM (1986) Fansidar prophylaxis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Int Med 105: 629PubMedGoogle Scholar
  8. Fischl MA, Richman DD, Grieco MH et al. (1987) The efficacy of azidothymidine ( AZT) in the treatment of patients with AIDS and AIDS related complex. N Engl J Med 317: 185–191Google Scholar
  9. Friedland SH, Salzman BR, Roger MF et al. (1986) Lack of transmission of HTLV-III/ LAV-infection to household contacts of patients with AIDS or AIDS related complex with oral candidiasis. N Engl J Med 314: 344–349PubMedCrossRefGoogle Scholar
  10. Glück D, Kubanek B (1988) Transfusionsmedi-zin/Blutbanken. In: Jäger H (Hrsg) AIDS und HIV-Infektionen. Ecomed, LandsbergGoogle Scholar
  11. Goedert JJ, Eyster ME, Friedman RM et al. (1988) Rate of heterosexual HIV-transmission and associated risk with HIV antigen. IV. Int. Conf. on AIDS. Stockholm 1988 (Abstract Nr. 4019)Google Scholar
  12. Golden JA, Chernoff D, Hollander H, Feigal D, Conte JE (1989) Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet, March 25; 654–657Google Scholar
  13. Gottlieb M, Galpin J, Thompkins J, Wilson D, Donatacci L, Soo W (1989) 2′,3′ Dideoxycyti-dine (DDC) in the treatment of patients with AIDS and ARC. V. Int. Conf. on AIDS. Montreal 1989 ( Abstract Nr. Th B03 )Google Scholar
  14. Hedl A (1988) Antivirale Therapie der HIV-Infektion. In: Jäger H (Hrsg) AIDS und HIV-In-fektionen. Ecomed, LandsbergGoogle Scholar
  15. Hussey RE, Richardson NE, Konuski M et al. (1988) A soluble CD 4 protein selectively in-hibing HIV-replication and syncytium formation. Nature 331: 78–81PubMedCrossRefGoogle Scholar
  16. Jäger H, Berlit K, Kellerman S et al. (1985) Immunologie alterations in healthy homosexual men. I. Int. Conf. on AIDS. Atlanta 1985Google Scholar
  17. Kahn J, Davis AJ, Groopman J, Kaplan L, Sherwin S, Volperding PA (1989) Pharmacokinetic studies of recombinant soluble CD 4 in patients with AIDS related complex. V. Int. Conf. on AIDS. Montreal 1989 ( Abstract Nr. Th B05 )Google Scholar
  18. Kennedey K, Fortney IA, Sokal D (1989) Breast-feading and HIV. Lancet 11: 333CrossRefGoogle Scholar
  19. Kochen MM (1988) Experimentale Virustase bei HIV-Infektionen und AIDS. In: Jäger H (Hrsg) AIDS und HIV-Infektionen. Ecomed, LandsbergGoogle Scholar
  20. Koenig ER (1989) International prostitutes and transmission of HIV. Lancet 8: 782 — 783CrossRefGoogle Scholar
  21. Larder B, Darby G, Richman D (1989) HIV with reduced sensitivity to Zidovudine ( AZT) isolated during prolonged therapy. Science 243: 1731–1734Google Scholar
  22. Lüthy R, Colla F, Schläpfer R, Täuber M, Siegenthaler W (1988) Diagnostik und Therapie der HIV-assoziierten Krankheiten. Internist 29: 82–91PubMedGoogle Scholar
  23. McGrath MS, Hwang KM, Caldwell SE et al. (1989) GLQ 223: An inhibitor of human immunodeficiency virus replication in acutely and chroically infectea cells of lymphocyte and mononuclear phagocyte lineage. Proc Nat Acad Sei USA 86: 2844–2848Google Scholar
  24. Minkowitz D (1989) Safe and Sappho. An AIDS primer for lesbians. Village Voice 21: 21Google Scholar
  25. Piot P, Plummer FA, Rey MA et al. (1987) Retro-spective epidemiology of HIV-infection in Nairobi population. J Infect Dis 155: 1108–1112PubMedCrossRefGoogle Scholar
  26. Pokrovsky VV, Eramova EU (1989) Nosocomial outbreak of HIV infection in Elista, USSR. V. Int. Conf. on AIDS. Montreal 1989 (Abstract Nr. WA05)Google Scholar
  27. Popescu M (1988) Therapie der Pneumocystis ca-rinii Pneumonie und Therapie der Toxoplasmose. In: Jäger H (Hrsg) AIDS und HIV-In-fektionen. Ecomed, LandsbergGoogle Scholar
  28. Proceeding of the National Academy of Sciences (1989)Google Scholar
  29. Quinn TC, Zacarias FRK, St. John RK (1989) AIDS in the Americas. An emerging public health crisis. N Engl J Med 320: 1005–1007Google Scholar
  30. Raviglione MC, Dinan WA, Pablos-Mendez A et al. (1988) Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfa-doxine in a human immunodeficiency virus infected person. Arch Int Med 148: 2683–2684CrossRefGoogle Scholar
  31. Rutherford GW, Hessol NA, Lifson AR et al. (1988) Natural history of HIV infection in a cohort of homosexual and bisexual men: A decade follow-up. IV. Int. Conf. on AIDS. Stockholm 1988 (Abstract Nr. 4096)Google Scholar
  32. Salzberg AM, Dolins SC (1989) The relation be-tween AID S cases and HIV prevalence. N Engl J Med 320: 936PubMedGoogle Scholar
  33. Sande MA, Volperding P (eds) (1988) The medical management of AIDS. Saunders, PhiladelphiaGoogle Scholar
  34. Sorensen JC, Guydish J, Constantini M, Batki SL (1989) Changes in needle sharing and syringe cleaning amoung San Francisco drug abusers. N Engl J Med 320: 807PubMedGoogle Scholar
  35. Schleuzig C, Jäger H, Rieder H, Hammel G, Po-pescu M (1989) Supervised physical exercise leads to psychological and immunological improvement in pre-AIDS patients. V. Int. Conf. on AIDS. Montreal 1989 ( Abstract Nr. TBP 301 )Google Scholar
  36. Yarchoan R, Thoma RV, Pluda JM et al. (1989) Escalating dose phase I study of intravenous and oral 2′,3′Dideoxyinosine (DDI) in patients with AIDS or ARC. V. Int. Conf. on AIDS. Montreal 1989 ( Abstract Nr. Th B04 )Google Scholar
  37. Wille R (1987) AIDS und Drogenabhängigkeit. In: Jäger H (Hrsg) Psychosoziale Betreuung von AIDS-und AIDS-Vorfeldpatienten. Thieme, StuttgartGoogle Scholar
  38. Women’s AIDS Network (1986) Lesbians and AIDS. What’s the connection. San Francisco AIDS Foundation 1986Google Scholar

Copyright information

© Springer-Verlag, Berlin, Heidelberg New York 1989

Authors and Affiliations

  • Hans Jäger

There are no affiliations available

Personalised recommendations